-
With so much stigma surrounding mental health issues in the workplace, managers and colleagues are often afraid of asking how someone is doing. Yet, noticing small warning signs and checking in with the employee shows caring and concern.January 13
Director of clinical operations & therapeutic developmentMeru Health -
Unlike private health insurance, Part D drug plans have no cap on patients’ 5% coinsurance costs once they hit $6,550 in drug spending, which forces patients to rely on financial assistance programs. These arrangements, however, do nothing to reduce drug prices.January 5
-
With access to in-person support limited during COVID, digital treatment platforms like Quit Genius can help employees with drug and alcohol addictions seek the help they need.January 4
-
Although it shows promise for reducing unnecessary healthcare spending and costs, and for improving decision making without adverse effects on clinical outcomes, shared decision making adoption has not been widespread.January 4
PresidentFAIR Health
-
The U.S. specialty market is expected to hit $310 billion by 2023, and 75% of the nearly 7,000 medications in development are specialty drugs.December 16
Executive Vice PresidentCVS Health
-
From COBRA premiums to long-term care, there are surprising uses for funds in these tax-advantaged accounts.December 4
-
COVID-19 has led more employees to engage in dangerous drug and alcohol abuse. With a cost of $740 billion annually in lost productivity and healthcare costs, how can employers intervene before it’s too late?December 2
-
Oregon became the first state in the U.S. to decriminalize use of hard drugs. What will this mean for employers who conduct drug testing?December 2
-
Health insurance companies will have to give their customers estimated out-of-pocket costs for prescription drugs and disclose to the public the negotiated prices they pay for drugs.November 19
-
